MIT engineers create nanoparticles for delivering personalized cancer vaccines
October 30, 2026
The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.
The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.
Data supporting the expanded clearance came from the HALT study involving 130 patients.